Sort
15,273 grants matching “antimicrobial resistance”
Molecular mechanisms of pathogenesis in staphylococci
$1,597,145Michael J Otto · Niaid Extramural Activities · Z01 · FY2007 · AI
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
$1,589,329Paul Clark Blainey · Broad Institute, Inc. · U19 · FY2021 · AI
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
$1,584,870Paul Clark Blainey · Broad Institute, Inc. · U19 · FY2023 · AI
CK20-004, Duke-UNC Prevention Epicenter Program for Protecting Patients from Infections, Antibiotics Resistance and Other Adverse Events
$1,583,624Deverick John Anderson · Duke University · U54 · FY2023 · CK
Task 11: Interventional Agent Development Services Program
$1,580,085Jon Mirsalis · Sri International · N01 · FY2017 · AI
Task C08: Manufacturing of a colon-delivery formulation platform of metronidazole for treating Clostridium difficile infection
$1,575,447Jon Mirsalis · Sri International · N01 · FY2020 · AI
Structural characterization of OM proteins from Gram-negative pathogens
$1,571,571Susan Buchanan · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Discovery, Design, and Development of Phosphonic Acid Antibiotics
$1,570,624William W. Metcalf · University Of Illinois At Urbana-Champaign · P01 · FY2015 · GM
Discovery, Design, and Development of Phosphonic Acid Antibiotics
$1,570,624William W. Metcalf · University Of Illinois At Urbana-Champaign · P01 · FY2014 · GM
Host Defense Against HIV-related Pulmonary Infections
$1,570,572Judd E Shellito · Lsu Health Sciences Center · P01 · FY2008 · HL
Nox family NADPH oxidases: roles in innate immunity and inflammatory disease
$1,568,875Thomas Leto · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Microbial exploration for new antimicrobial discovery
$1,554,067Akintunde Emiola · National Institute Of Dental & Craniofacial Research · ZIA · FY2023 · DE
OPTIMIZE - CCC - Lead Application
$1,550,633Bonnie W Ramsey · Seattle Children'S Hospital · U01 · FY2015 · HL
Center for Innovative Diagnostics for Infectious Diseases
$1,545,823Yukari C Manabe · Johns Hopkins University · U54 · FY2023 · EB
Public Health Prevention Fund (PPHF) Ventilator Associated Pneumonia ACA
$1,544,184Michael Klompas · Harvard Pilgrim Health Care, Inc. · U54 · FY2011 · CK
Host Defense Against HIV-related Pulmonary Infections
$1,543,865Louisiana State Univ Hsc New Orleans · P01 · FY2004 · HL
Novel DNA encoded monoclonal antibodies (DMAbs) for control of Antimicrobial Resistant (AMR) Pseudomonas aeruginosa infection
$1,541,486David B. Weiner · Wistar Institute · R01 · FY2019 · AI
Center for Innovative Diagnostics for Infectious Diseases
$1,537,364Yukari C Manabe · Johns Hopkins University · U54 · FY2024 · EB
Mechanisms Of Drug-induced Toxicities
$1,536,028Lance R Pohl · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Structure-based microbially targeted prodrugs
$1,535,250Audrey Ragan Odom John · Children'S Hosp Of Philadelphia · R01 · FY2025 · AI
Mechanisms of protection against shigellosis in children
$1,535,247Marcela F Pasetti · University Of Maryland Baltimore · R01 · FY2025 · AI
Statistical Mechanics of Mutational Ensembles for Adaptive Evolution
$1,534,925Olivier Lichtarge · Baylor College Of Medicine · · FY2024 · BIO
Center for Innovative Diagnostics for Infectious Diseases
$1,532,027Yukari C Manabe · Johns Hopkins University · U54 · FY2025 · EB
Innovative technologies to transform antibiotic discovery. Project 2 Engineering antibiotic sensitization therapies
$1,531,949Paul Clark Blainey · Broad Institute, Inc. · U19 · FY2020 · AI
Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs.
$1,529,428Manav Mehta · Gel4med, Inc. · R44 · FY2024 · DK